| Trial ID: | L5046 |
| Source ID: | NCT00609102
|
| Associated Drug: |
Placebo
|
| Title: |
Antioxidant Treatment of Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Placebo|DRUG: n-aceylcysteine
|
| Outcome Measures: |
Primary: Blood glucose, 3 months | Secondary: HbA1c levels, 3 months
|
| Sponsor/Collaborators: |
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
EARLY_PHASE1
|
| Enrollment: |
44
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
|
| Start Date: |
2008-07
|
| Completion Date: |
2013-09
|
| Results First Posted: |
|
| Last Update Posted: |
2014-12-24
|
| Locations: |
Pacific Northwest Research Institute, Seattle, Washington, 98122, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT00609102
|
